A novel polyoxometalate cluster, i.e., Na 1.5 H 4.5 [(CH 3 ) 4 N] 2 {[Mn(CO) 3 ] 4 (Se 2 W 11 O 43 )}·9H 2 O ( 1 ), has been successfully synthesized under moderately acidic conditions. Compound 1 contains four electron-donating {Mn(CO) 3 } + organometallic entities, which are grafted over an unprecedented heteropolytungstate electron-acceptor group. Compound 1 was further structurally characterized by various physicochemical techniques like elemental analyses, inductively coupled plasma (ICP) analyses, IR and UV–vis spectroscopy, electrochemistry, and single-crystal X-ray diffraction, and so on. The polyoxoanion of 1 comprises a novel {Se 2 W 11 } fragment, which is obtained from molecular assembly of rare {SeW 3 } and {SeW 8 } species. Evaluation of the data from solution-state IR spectrum showed excellent agreement with the solid state IR spectrum, indicating the intact clusters in the CH 3 CN/Na 2 SO 4 solvent. Also, negative electrospray ionization mass spectrometry (ESI-MS) was an alternative tool to verify the stability of 1 in the mixed solvent. Additionally, the resulting hybrid can act as a catalyst for cyclic carbonate formation from the reactants epoxides and CO 2 under modest reaction conditions in conjunction with a 1-ethyl-1-methylpyrrolidinium bromide ( 2 ). The good activity can be substantiated due to the cooperative influence of polyoxoanion and Br – ions. Complex 1 can also be easily recycled and reused three times without obvious decrease of catalytic activity.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: